Press Releases

- Continue to anticipate SurgiBot FDA clearance by the end of the first quarter of 2016 - - Strengthens balance sheet with $18M of equity raised - RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT: TRXC ), a medical device company that is pioneering the use of robotics

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 5 th Annual Global

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, will present at the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2015.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Steven Boudrez , an experienced robotic surgery sales executive, has been appointed as

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at two upcoming investor conferences.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release third quarter 2015 financial and operating results before the market opens on Thursday, November 5, 2015 . Todd M. Pope , President & Chief Executive Officer and Joseph P.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Anthony Fernando , an executive with significant global experience, has been appointed to

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, will ring The Opening Bell ® of the New York Stock Exchange (NYSE) on Wednesday, September 23, 2015 to

Creates a global surgical robotics company with a compelling product portfolio Expected to accelerate commercialization timeline and revenue ramp RESEARCH TRIANGLE PARK, N.C. & MILAN --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of